Pellejero-Sagastizabal, Galadriel https://orcid.org/0000-0002-2728-5435
Morte-Romea, Elena
Girón Ortega, José Antonio
Paño-Pardo, José Ramón
Fernández Guerrero, Raquel
Guerrero, Francisca
Montes de Oca, Montserrat
Jiménez-Jorge, Silvia
Palacios-Baena, Zaira R.
Rodríguez-Baño, Jesús
Retamar-Gentil, Pilar
,
Montes de Oca Arjona, Montserrat
Galán Sánchez, Fátima
Rodríguez Mateos, María Eugenia
Girón-González, José Antonio
Martín Aspas, Andrés
Sánchez Tembleque, Claudio
Guerrero Sánchez, Francisca María
Morte-Romea, Elena
Pellejero-Sagastizabal, Galadriel
Luque Gómez, Pilar
Paño-Pardo, José Ramón
Sierra, José Luis
Letona Gimenez, Santiago
Palacián, Pilar
Rodriguez, Nora Mariela
Arenere Mendoza, Mercedes
Allende Bandrés, Maria Ángeles
Fresquet Molina, Raquel
Navarro Pardo, Irene
Girón Ortega, José Antonio
Fernández Guerero, Raquel
Retamar-Gentil, Pilar
Palacios-Baena, Zaira
de Cueto, Marina
Beltrán García, Margarita
Cantón Bulnes, María Luisa
Suarti, Lorenzo Roberto
Rodríguez-Baño, Jesús
Funding for this research was provided by:
the Spanish Network for Research in Infectious Diseases (RD16/0016/0001 and RD16CIII/0004/0002)
Acción Estratégica en Salud, Carlos III Health Research Institute (ISCIII), Ministry of Science and Innovation (PI17/01809)
CIBERINFEC (CB21/13/00012 and CB21/13/00087)
European Development Regional Fund “A way to achieve Europe (Operative Program Intelligence Growth 2014–2020)
ERDF/ESF, “Investing in your future.”
Spanish Clinical Research and Clinical Trials Platform (PT17/0017/0012, PT 20/00123 and PT23/00135)
Article History
Received: 19 December 2025
Accepted: 11 August 2026
First Online: 29 August 2026
Declarations
Competing interests: The authors declare that they have no competing interests.